Author details

Full Name

Craig N Kreklywich

Affiliation

Vaccine and Gene Therapy Institute, Oregon Health and Science University

ORCID

Career Start Year

1991

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37398229	The pentameric complex is not required for vertical transmission of cytomegalovirus in seronegative pregnant rhesus macaques.	bioRxiv	2023
37782657	Proximity-dependent mapping of the HCMV US28 interactome identifies RhoGEF signaling as a requirement for efficient viral reactivation.	PLoS Pathog	2023
37983245	Mayaro virus pathogenesis and immunity in rhesus macaques.	PLoS Negl Trop Dis	2023
37923717	Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology.	Nat Commun	2023
35788221	Development of a next-generation chikungunya virus vaccine based on the HydroVax platform.	PLoS Pathog	2022
33205500	Macrophage depletion of CMV latently infected donor hearts ameliorates recipient accelerated chronic rejection.	Transpl Infect Dis	2021
33601113	Rat and human cytomegalovirus ORF116 encodes a virion envelope glycoprotein required for infectivity.	Virology	2021
33793555	Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.	PLoS Negl Trop Dis	2021
33835811	Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors.	J Med Chem	2021
33405337	Blocking the IL-1 receptor reduces cardiac transplant ischemia and reperfusion injury and mitigates CMV-accelerated chronic rejection.	Am J Transplant	2021
33228102	Rat Cytomegalovirus Virion-Associated Proteins R131 and R129 Are Necessary for Infection of Macrophages and Dendritic Cells.	Pathogens	2020
31935257	A neonatal nonhuman primate model of gestational Zika virus infection with evidence of microencephaly, seizures and cardiomyopathy.	PLoS One	2020
30917980	Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs.	Antimicrob Agents Chemother	2019
31736977	Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease.	Front Immunol	2019
31848362	Characterization of a live-attenuated HCMV-based vaccine platform.	Sci Rep	2019
31431555	Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34[+] Hematopoietic Progenitor Cells and Humanized NSG Mice.	mBio	2019
31316006	Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity.	Sci Transl Med	2019
29343712	Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology.	Nat Commun	2018
28628616	Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques.	PLoS Negl Trop Dis	2017
28278237	Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.	PLoS Pathog	2017
28380070	Correction: Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.	PLoS Pathog	2017
28428537	Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice.	Sci Rep	2017
25766876	Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-NaÃ¯ve Recipients of Infected Donor Allograft Hearts.	Am J Transplant	2015
24161922	HCMV infection of humanized mice after transplantation of G-CSF-mobilized peripheral blood stem cells from HCMV-seropositive donors.	Biol Blood Marrow Transplant	2014
24829346	Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.	J Virol	2014
24639226	Fluorescence-based laser capture microscopy technology facilitates identification of critical in vivo cytomegalovirus transcriptional programs.	Methods Mol Biol	2014
24691437	Cytomegalovirus pp65 limits dissemination but is dispensable for persistence.	J Clin Invest	2014
23936572	Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.	PLoS Negl Trop Dis	2013
22915808	Cytomegalovirus CC chemokine promotes immune cell migration.	J Virol	2012
20980502	Cytomegalovirus microRNA expression is tissue specific and is associated with persistence.	J Virol	2011
22241980	A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection.	PLoS Pathog	2011
22052378	Simian varicella virus gene expression during acute and latent infection of rhesus macaques.	J Neurovirol	2011
21199347	Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naÃ¯ve recipients.	Am J Transplant	2011
20930069	IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin.	Blood	2011
20833379	Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model.	Cell Host Microbe	2010
19349057	Rat cytomegalovirus infection depletes MHC II in bone marrow derived dendritic cells.	Virology	2009
18093265	The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants.	Am J Transplant	2008
18448536	Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing.	J Virol	2008
17251289	Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro.	J Virol	2007
17175227	Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profiles.	Transplant Proc	2006
15707397	Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33.	Am J Transplant	2005
16051870	Mouse cytomegalovirus M33 is necessary and sufficient in virus-induced vascular smooth muscle cell migration.	J Virol	2005
12525653	Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants.	J Virol	2003
11907411	Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants.	Transplantation	2002
11267529	Kinetics and development of CMV-accelerated transplant vascular sclerosis in rat cardiac allografts is linked to early increase in chemokine expression and presence of virus.	Transplant Proc	2001
8508678	Linkage mapping detects two secondary microdeletions in cell hybrid HHW1064, used to isolate DNA probes from within 5q11.2-->q13.3.	Cytogenet Cell Genet	1993
1674144	A polymorphic DNA marker at the D8S131 locus.	Nucleic Acids Res	1991
1762937	Dinucleotide repeat polymorphism at the D5S260 locus on chromosome 5q.	Nucleic Acids Res	1991
1945862	Dinucleotide repeat polymorphisms at the D5S257 and D5S268 loci on chromosome 5p.	Nucleic Acids Res	1991

1 - 49 of 49

David Sachs

Icahn School of Medicine at Mount Sinai

Career Start Year 2013

Number of shared co-authors 0

Mary K McCarthy

University of Colorado School of Medicine

Career Start Year 2012

Number of shared co-authors 5

Craig B Wilen

Yale School of Medicine

Career Start Year 2010

Number of shared co-authors 1

Thomas J Gardner

Icahn School of Medicine at Mount Sinai

Career Start Year 2009

Number of shared co-authors 0

Stephanie A Montgomery

and Lineberger Comprehensive Cancer Center, University of North Carolina System

Career Start Year 2006

Number of shared co-authors 4

Cherie T Ng

The Scripps Research Institute

Career Start Year 2004

Number of shared co-authors 0

Rebecca S LaRue

Minnesota Supercomputing Institute, University of Minnesota

Career Start Year 2003

Number of shared co-authors 0

Travis R Taylor

University of Toledo

Career Start Year 2002

Number of shared co-authors 0

Sean C Proll

Fred Hutchinson Cancer Research Center

Career Start Year 2001

Number of shared co-authors 6

Lauren M Hook

Perelman School of Medicine, University of Pennsylvania

Career Start Year 2000

Number of shared co-authors 7

Xiao-Yi Yan

Liaoning Normal University

Career Start Year 2000

Number of shared co-authors 0

Edward P Browne

University of North Carolina at Chapel Hill

Career Start Year 2000

Number of shared co-authors 0

Larissa B Thackray

Washington University School of Medicine

Career Start Year 1996

Number of shared co-authors 6

J??rgen Haas

University of Edinburgh

Career Start Year 1996

Number of shared co-authors 1

Shelly J Robertson

National Institute of Allergy and Infectious Diseases

Career Start Year 1995

Number of shared co-authors 1

Ande West

University of North Carolina at Chapel Hill

Career Start Year 1993

Number of shared co-authors 6

Lubbertus C F Mulder

Icahn School of Medicine at Mount Sinai

Career Start Year 1993

Number of shared co-authors 0

Laurent Coscoy

University of California Berkeley

Career Start Year 1993

Number of shared co-authors 1

Ren Sun

University of California los angeles

Career Start Year 1992

Number of shared co-authors 0

John W Barrett

University of Western Ontario

Career Start Year 1992

Number of shared co-authors 0

Keith R Jerome

Fred Hutchinson Cancer Center

Career Start Year 1991

Number of shared co-authors 0

P Robert Beatty

School of Public Health, University of California berkeley

Career Start Year 1990

Number of shared co-authors 1

Akiko Iwasaki

Yale University

Career Start Year 1990

Number of shared co-authors 1

Peter Ghazal

UK System Immunity Research Institute, Cardiff University

Career Start Year 1985

Number of shared co-authors 1

Steven G Widen

University of Texas Medical Branch

Career Start Year 1983

Number of shared co-authors 0

William J Britt

Heersink School of Medicine, University of Alabama at Birmingham

Career Start Year 1979

Number of shared co-authors 8

Robert F Garry

Tulane University School of Medicine

Career Start Year 1974

Number of shared co-authors 1

Ulrich H Koszinowski

Max von Pettenkofer-Institute, Ludwig-Maximilians-Universitat Munchen

Career Start Year 1973

Number of shared co-authors 0

Alan C Whitmore

University of North Carolina at Chapel Hill

Career Start Year 1973

Number of shared co-authors 4

Ronald J Messer

National Institute of Allergy and Infectious Diseases, National Institutes of Health

Career Start Year 1972

Number of shared co-authors 0

row(s) 1 - 30 of 30

Daniel N Streblow

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 45

Jay A Nelson

Oregon Health and Science University

Co-authored papers 18

Victor R DeFilippis

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 14

Michael Denton

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 13

Patrizia Caposio

Vaccine and Gene Therapy Institute, Oregon Health & Science University

Co-authored papers 6

Alec J Hirsch

Vaccine & Gene Therapy Institute, Oregon Health & Science University

Co-authored papers 6

Jessica L Smith

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 5

Louis J Picker

Vaccine and Gene Therapy Institute, Oregon Health & Science University

Co-authored papers 5

Thomas E Morrison

University of Colorado Anschutz Medical Campus

Co-authored papers 5

Mark T Heise

University of North Carolina at Chapel Hill.

Co-authored papers 4

Lindsey B Crawford

Vaccine and Gene Therapy Institute, Oregon Health & Science University

Co-authored papers 4

Michael S Diamond

Washington University School of Medicine

Co-authored papers 3

Devorah C Goldman

Oregon Health & Science University

Co-authored papers 3

William H Fleming

Oregon Health & Science University

Co-authored papers 3

Richard D Smith

Pacific Northwest National Laboratory

Co-authored papers 2

James E Crowe

Vanderbilt University Medical Center

Co-authored papers 2

Timothy Alexander

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 2

Finn Grey

The Roslin Institute, The University of Edinburgh

Co-authored papers 2

Andrew D Yurochko

Louisiana State University

Co-authored papers 2

Christopher L Corless

Oregon Health & Science University

Co-authored papers 2

Meaghan H Hancock

Vaccine and Gene Therapy Institute, Oregon Health & Science University

Co-authored papers 2

David G Camp

Co-authored papers 2

Chan-Ki Min

Co-authored papers 1

Adam T Mayo

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 1

Robert M Friedman

J. Craig Venter Institute

Co-authored papers 1

Jon M Jacobs

Pacific Northwest National Laboratory

Co-authored papers 1

Patricia Smith

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 1

Robert P Searles

Oregon Health & Science University

Co-authored papers 1

Robert H Carnahan

Vanderbilt University Medical Center

Co-authored papers 1

Shannon K McWeeney

Oregon Health & Science University, University of California Berkeley

Co-authored papers 1

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators